Kofnix 5 mg/ml (Pediatric Drops)
15 ml bottle: ৳ 50.00
Medicine Details
Category | Details |
---|---|
Generic | Butamirate citrate |
Company | Aci limited |
Also available as |
Title
Kofnix Cough Syrup
Categories
- Medicine
- Healthcare
- Pharmaceutical
Description
Kofnix is a cough syrup that is used to relieve dry (non-productive) cough. It can also be used for pre & post-operative cough sedation, acute cough, whooping cough, and cough due to acute lower respiratory tract infections. The active ingredient, Butamirate Citrate, acts directly on the brain's cough center to suppress cough. The syrup is available in tablet and syrup forms for adults, children, and adolescents.
Attributes
- Dimensions: Available in tablet and syrup forms
- Color Options: N/A
- Functions:
- Relieves dry cough
- Suppresses cough reflex
- Sedates pre & post-operative cough
- Acts as a cough suppressant
- Materials: Butamirate Citrate
- Technical Specifications:
- Tablet Dosage for Adults: 2-3 tablets daily
- Syrup Dosage for Adults: 15 ml 4 times daily
- Tablet Dosage for Adolescent (12+ years): 1-2 tablets daily
- Syrup Dosage for Children (3-6 yrs): 5 ml 3 times daily
- Syrup Dosage for Children (6-12 yrs): 10 ml 3 times daily
- Syrup Dosage for Adolescent: 15 ml 3 times daily
- Pediatric Drops Dosage for Children (2 months-1 yr): 0.50 ml 4 times daily
- Pediatric Drops Dosage for Children (1-3 yrs): 0.75 ml 4 times daily
- Pharmacokinetics: Rapid and complete absorption after oral administration, peak concentration reached within 9 hours, protein-bound and plasma elimination half-life of about 13 hours
- Design Elements: Standard pharmaceutical packaging
- Usability Features:
- Child-resistant packaging
- Available in pediatric drops for infants and young children
- Interaction: Contraindicated with expectorants
- Contraindications: Hypersensitivity to Butamirate Citrate
- Side Effects:
- Tolerance is good
- Rare cases of rash, nausea, diarrhea, and vertigo observed
- Pregnancy & Lactation: Avoid use during first trimester, caution during remainder of pregnancy, weigh benefits against risks during breastfeeding
- Precautions & Warnings: Avoid concomitant use with expectorants, consult doctor if cough persists for more than 7 days (3 days in children under 12 years)
- Overdose Effects: May cause drowsiness, nausea, vomiting, diarrhea, loss of balance, and hypotension
- Therapeutic Class: Cough suppressant
- Storage Conditions: Store below 30°C, away from light and moisture, keep out of reach of children
Related Brands
- Tussibic 7.5 mg/5 ml (Syrup) - unimed-unihealth-pharmaceuticals-ltd
- Mirakof 5 mg/ml (Pediatric Drops) - square-pharmaceuticals-plc
- Butaret SR 50 mg (Tablet (Sustained Release)) - opsonin-pharma-ltd
- Butasiv 50 mg (Tablet (Sustained Release)) - jenphar-bangladesh-ltd
- Butasiv 7.5 mg/5 ml (Syrup) - jenphar-bangladesh-ltd